Senti Biosciences, a pioneering force in synthetic biology, has successfully raised an impressive $37.6 million in its latest funding round, marking a significant milestone in the company’s mission to revolutionize treatment against complex diseases. With the objective of creating next-generation medicines that can outsmart ailments in ways previously deemed impossible, Senti is focused on developing cutting-edge cell and gene therapies driven by innovative “gene circuits.” These circuits, engineered from proprietary DNA sequences, empower cells to operate with biological logic, allowing them to sense their environment, process information, and tailor their responses accordingly. The recently acquired funds will be instrumental in advancing Senti's synthetic biology platform, enhancing the intelligence of its therapies, and broadening the spectrum of diseases that these treatments can effectively target. In a landscape where many conventional medicines fall short, Senti’s commitment to improving therapeutic effectiveness stands to transform patient outcomes and redefine the approach to treating complex health challenges. As Senti Biosciences continues to push the boundaries of medical science, it remains dedicated to harnessing the power of biology to deliver smarter, more adaptable, and ultimately more effective therapies. For further insights into Senti's groundbreaking work and the future of disease treatment, visit their website at https://www.sentibio.com.
Senti Biosciences Secures $37.6 Million in Funding for Next-Generation Cell and Gene Therapies
Recently funded · $37.6MHealthcare
Get the full Senti Biosciences company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
